Variant report
Variant | nsv877826 |
---|---|
Chromosome Location | chr3:163645437-163694975 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:16)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:16 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:219388883..219389633-chr3:163652052..163652630,2 | MCF-7 | breast: | |
2 | chr3:163660440..163662829-chr3:163666000..163668542,2 | K562 | blood: | |
3 | chr3:163219408..163221189-chr3:163663438..163665910,2 | K562 | blood: | |
4 | chr3:163664276..163666199-chr3:163667456..163669439,2 | MCF-7 | breast: | |
5 | chr3:163660440..163662829-chr3:163666000..163668542,2 | K562 | blood: | |
6 | chr3:163674728..163675758-chr3:164903457..164904093,3 | MCF-7 | breast: | |
7 | chr3:163674674..163675466-chr3:164524045..164524647,3 | MCF-7 | breast: | |
8 | chr3:163669046..163669790-chr3:164903266..164903861,2 | MCF-7 | breast: | |
9 | chr3:163639924..163641654-chr3:163663861..163665823,2 | MCF-7 | breast: | |
10 | chr3:163689823..163692046-chr3:163703767..163706359,2 | K562 | blood: | |
11 | chr3:163497409..163497997-chr3:163668939..163669921,2 | MCF-7 | breast: | |
12 | chr3:163664276..163666199-chr3:163667456..163669439,2 | MCF-7 | breast: | |
13 | chr3:163647521..163649115-chr3:163652164..163654381,2 | MCF-7 | breast: | |
14 | chr3:163676571..163679360-chr3:163699055..163700602,2 | MCF-7 | breast: | |
15 | chr3:163647521..163649115-chr3:163652164..163654381,2 | MCF-7 | breast: | |
16 | chr3:163634067..163635345-chr3:163668973..163669822,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9822851 | chr3:163645437-163645438 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs144601707 | chr3:163645446-163645447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114428256 | chr3:163645447-163645448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs192493111 | chr3:163645562-163645563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527993817 | chr3:163645628-163645629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184590041 | chr3:163645629-163645630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566927375 | chr3:163645666-163645667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535889450 | chr3:163645685-163645686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9843404 | chr3:163645745-163645746 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs73166432 | chr3:163645781-163645782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs74774805 | chr3:163645798-163645799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73166433 | chr3:163645810-163645811 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs560701624 | chr3:163645826-163645827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572332473 | chr3:163645839-163645840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79357780 | chr3:163645860-163645861 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147586856 | chr3:163645898-163645899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142021959 | chr3:163645901-163645902 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542693557 | chr3:163645937-163645938 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562981301 | chr3:163646072-163646073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144311479 | chr3:163646088-163646089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16847362 | chr3:163646148-163646149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569533913 | chr3:163646167-163646168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567404780 | chr3:163646238-163646239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34283449 | chr3:163646247-163646248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565148429 | chr3:163646315-163646316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375481008 | chr3:163646363-163646364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189232014 | chr3:163646410-163646411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10428115 | chr3:163646535-163646536 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs561285042 | chr3:163646615-163646616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529676105 | chr3:163646670-163646671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368764139 | chr3:163646685-163646686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375904789 | chr3:163646876-163646877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73166434 | chr3:163646881-163646882 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs3849456 | chr3:163646892-163646893 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs115702686 | chr3:163646930-163646931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558128912 | chr3:163646968-163646969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145978241 | chr3:163647015-163647016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548339199 | chr3:163647062-163647063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552305871 | chr3:163647179-163647180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371612987 | chr3:163647198-163647199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs3849457 | chr3:163647218-163647219 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs554890651 | chr3:163647300-163647301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574816329 | chr3:163647307-163647308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556929296 | chr3:163647324-163647325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs113476064 | chr3:163647358-163647359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536623284 | chr3:163647369-163647370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372678229 | chr3:163647381-163647382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568885325 | chr3:163647399-163647400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34414110 | chr3:163647403-163647404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556299139 | chr3:163647410-163647411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163642800-163646000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr3:163643800-163646400 | Weak transcription | Stomach Mucosa | stomach |
3 | chr3:163645800-163646000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
4 | chr3:163646000-163646600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
5 | chr3:163646000-163650600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr3:163646400-163647800 | Enhancers | Stomach Mucosa | stomach |
7 | chr3:163647400-163647800 | Enhancers | Fetal Intestine Large | intestine |
8 | chr3:163650600-163651000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr3:163657800-163658200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr3:163657800-163658200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr3:163670400-163670600 | Enhancers | Pancreas | Pancrea |
12 | chr3:163670800-163671200 | Weak transcription | Pancreas | Pancrea |
13 | chr3:163671200-163671800 | Enhancers | Pancreas | Pancrea |
14 | chr3:163671600-163671800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr3:163671800-163684800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr3:163686000-163686400 | Active TSS | Gastric | stomach |
17 | chr3:163686200-163686600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |